1Grundy SN,Reeker D,Clark LT,et al. National cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel Ⅲ )[J]. JAMA,2001,285: 2486～2497.
2Kirsten AM,Sheila MW,Jim IM,et al. Diagnosing insulin resistance in the general population[J]. Diabetes Care, 2001,24: 460-464.
3Bonora E,Targher G,Alberiche M,et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity[J]. Diabetes Care, 2000,23: 57-63.
4Tavema MJ,Pacber N,Bruzzo F,et al. Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in type 2 diabetes[J]. Diabet Med, 2001,18(7): 584-587.
5Thomas A, Buchanan. Pancreatic B- cell defects in gestational diabetes: Implications for the pathogenesis and prevention of type 2 diabetcs[J]. J Clin Endocrinol Metab, 2001,86 : 989 -993.
6Hanson RL,Pratley RE, Bogardus C, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies[J]. Am J Epidemiol, 2002,151: 190-198.
7Unwin N,Shaw J, Zimmet P. International Diabetes Federation IGF/IGT Consensus Statement. Impaired glucose tolerance and impaired fadting glycaemia: the current status on definition and intervention[J]. Diabetic Med, 2002,19: 708～732.
8HOPE Research Group. Angiotensin converting engyme inhibitor-effect of ramipril on cardiovascular events in high risk patients[J]. N Engl J Med,2000,342: 311-316.
9Amwrican Diabetes Association. Screening for diabetes[J]. Diabetes Care,2002,25suppl 1: S21-S24.
10Narayan KMV, Imperatore G. Benjamin SM, et al. Targeteting people with pre-diabetws[J]. BMJ, 2002,325: 403-404.
二级参考文献6
1U. k. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2diabetes (UKPDS 33). Lancet, 1998, 352:837-853.
2Looker HC, Knowler WC, Hanson RL. Changes in BMI and Weight before and after the development of type 2 diabetes. Diabetes Care, 2001, 24: 1917-1923.
3D. R. Matthews,J. P. Hosker,A. S. Rudenski,B. A. Naylor,D. F. Treacher,R. C. Turner. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man[J] 1985,Diabetologia(7):412～419
6Bergman M. Pathophysiology of prediabetes and treatment im- plications for the prevention of type 2 diabetes mellitus[J]. En- docrine,2013,43(3) :504-513.
7Gallwitz B,Kazda C,Kraus P,et al. Contribution of insulin de- ficiency and insulin resistance to the development of type 2 dia- betes:nature of early stage diabetes[J]. Aeta diabetologiea, 2013,50(1) :39-45.
9Matthews D, Hosker J, Rudenski A, et al. Homeostasis model assessment:insulin resistance and 13-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabeto- logia, 1985,28(7) ..412-419.
10A E,O K,A R,et al. Association between physical activity and insulin resistance in Iranian adults National Surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) [J]. Preventive medicine: An international journal devoted to practice and theory, 2009,49(5) 402-406.
